George Goldin, MD, FACP, FACG, AGAF

Subspecialty Education Director, Gastroenterology


EDUCATION
Undergraduate:  Vanderbilt University, Nashville, Tennessee – BS (Biology)
Medical School:  Mercer University School of Medicine, Macon, Georgia
Residency: Internal Medicine – Vanderbilt University Medical Center, Nashville, Tennessee
Fellowship: Gastroenterology and Hepatology – University of Virginia Health Sciences Center, Charlottesville, Virginia

APPOINTMENTS
Assistant Professor of Medicine, Medical College of Georgia

RESEARCH/PUBLICATIONS

Presentations

G.F. Goldin, M. Marcinkiewicz, L. P. Bityutskiy, J. Sarosiek, R. W. McCallum. Esophagoprotective Potential of Cisapride: A Novel Rationale For Its Use In Gastroesophageal Reflux Disease. Oral Presentation, AGA 1996, San Francisco.

George F. Goldin, M.D., Rolland C. Dickson, M.D., Bruce Dunne, Ph.D., Julia Wendon, M.D., Roger Williams, M.D. Purine Nucleoside Phosphorylase: A Potential Prognostic Factor In Acetaminophen Hepatotoxicity. Oral Presentation, AGA/ASGE/AASLD Young Investigator’s Conference 1996, Couer d’ Alene, Idaho

Abstracts 

Marcinkiewicz M, Han K, Zbroch T, Poplawski C, Gramley W, Goldin G, Sarosiek J. The Potential Role of the Esophageal Pre-Epithelial Barrier Components in the Maintenance oflntegrity of the Esophageal Mucosa in Patients With Endoscopically Negative Gastroesophageal Reflux Disease (abstract). Gastroenterology 2000 Ju1;95(7):1652-60

George F. Goldin, M.D., Rolland C. Dickson, M.D., Bruce Dunne, Ph.D., Julia Wendon, M.D., Roger Williams, M.D. Purine Nucleoside Phosphorylase: A Potential Prognostic Factor In Acetaminophen Hepatotoxicity (abstract). Poster Presentation, AASLD Nov 1996, Chicago.

G.F. Goldin, M. Marcinkiewicz, R. W. McCallum. Enhancement of Esophageal Bicarbonate and Non-bicarbonate Buffering Capacity by Cisapride: Its Potential Role in Strengthening the Esophageal Mucosa! Barrier (abstract). Poster Presentation, ACG Oct 1996, Seattle.

Marcinkiewicz, G. F. Goldin, R. W. McCallum, J. Sarosiek. Potentiation of Salivary Peptide Growth Factor Output, Mediated by Esophagosalivary Reflex, By Cisapride Administration: The Role of Serotonergic Pathway (abstract). Poster Presentation, ACG Oct 1996, Seattle.

Marcinkiewicz, C. J. Scheurich, G. F. Goldin, J. Sarosiek, R. W. McCallum. Salivary Glycoconjugate (Mucin): Is it the Answer to the Lower Prevalence of Gastroesophageal Reflux Disease in African-Americans? (abstract). Poster Presentation, ACG Oct 1996, Seattle.

Marcinkiewicz, G. F. Goldin, L. P. Bityutskiy, R. W. McCallum, J. Sarosiek.  A Stimulatory Impact of Cisapride Administration on Salivary Buffering Capacity: Its Potential Therapeutic Benefit For Patients With Gastroesophageal Reflux Disease (abstract). Gastroenterology  110(4):A186, 1996.

J. Sears, C. Duckworth, D. H. Balaban, K. H. Han, G. F. Goldin, D. H. Oelsner, Yeaton. Erythromycin Versus Gastric Lavage For Pre-Endoscopic Preparation of Patients With Upper Gastrointestinal Bleeding (abstract). Gastrointestinal Endoscopy 43(4):358, 1996.

Marcinkiewicz, B. J. van der Linden, G. F. Goldin, D. A. Peura, J. Sarosiek. Impaired Generation of Prostaglandin E2 in Patients With Gastric Ulcer Despite Helicobacter pylori-induced Inflammatory Changes (abstract). Gastroenterology 110(4):A185, 1996.

Marcinkiewicz, G. F. Goldin, C. J. Scheurich, M. C Edmunds, Z. Namiot, W. McCallum. Salivary Mucin Secretion Is Compromised In Patients With Grade III But Not Grade II Reflux Esophagitis (abstract). Gastroenterology 110(4):A186, 1996.

Marcinkiewicz, B. J. van der Linden, G. F. Goldin, J. Sarosiek. Interrelationship Between pH And Prostaglandin E2 Concentration In Gastric Juice Is Compromised By Helicobacter pylori Colonization (abstract). Gastroenterology 110(4):Al85, 1996.

Marcinkiewicz, B. J. van der Linden, G. F. Goldin, D. A. Peura, J. Sarosiek. The Molar Between Prostaglandin E2 And Hydrogen Ion Concentrations In Juice As A Potential Predictor of The Development of Endoscopic Mucosa! Damage (abstract). Gastroenterology 110(4):A249, 1996.

Publications

G. F. Goldin, M.D., M. Marcinkiewicz, M.D., L. P. Bityutskiy, M.D., R. W. McCallum, M.D., J. Sarosiek, M.D. Esophagoprotective Potential of Cisapride: Its Additional Benefit for Gastroesophageal Reflux Disease. Digestive Diseases and Sciences. 1997 Jul; 42(7):1362-9.

Marcinkiewicz, B. Van Der Linden, D. Peura, G. Goldin, S. Parolisi, J. Sarosiek. Impact of Helicobacter pylori Colonization on Immunoreactive Epidermal Growth Factor and Transforming Growth Factor-a in Gastric Juice: Its Potential Pathogenetic Implications. Digestive Diseases and Sciences. 1996 Nov; 41(11):2150-5.

F. Goldin, M.D., D. A. Peura, M.D. Stress-Related Mucosal Damage. In M. B. Fennerty (ed.): Gastrointestinal Endoscopy Clinics of North America. B. Saunders, Philadelphia, July 1996.

G. F. Goldin, M.D., D. A. Peura, M.D. Gastrointestinal Procedures, Chapters 1 & 2.  In PM Suratt, RS Gibson (eds.): Manual of Medical Procedures. CV Mosby, St. Louis, 1996.

M. Yoshida, M.D., G. F. Goldin, M.D., C. Mathews. Gastrointestinal Disease.  In J. Bergin (ed.): Medical Recall. Williams & Wilkins, Baltimore, 1996.

George Goldin, MD, FACP, FACG, AGAF